(Reuters Health) – For people conscious about their heart health, a new study suggests it may be best to eat fish instead of taking individual omega-3 fatty acids in supplement form.After reviewing information on the habits and fatty-acid blood levels of more than 20,000 male doctors, researchers fo

This report examines global experiences in coordinated procurement of health technologies and explores their potential application for antibiotics in ASEAN. Drawing on a scoping review and stakeholder consultations, it analyses key determinants—including governance, financing, regulatory systems, an

Abstract Aim Kidney failure patients in the Philippines have free choice on their kidney replacement therapy (KRT), with a majority choosing haemodialysis (HD) over peritoneal dialysis (PD) and transplantation despite the inadequate coverage of HD. Although national health insurance coverage is

In the year after an expert panel’s recommendation that women delay regular breast cancer screenings until age 50, the number of women in their 40s undergoing mammograms slightly declined, a new study shows.The study, carried out by the Mayo Clinic, found a drop of roughly 6 percent in the number of

In the year after an expert panel’s recommendation that women delay regular breast cancer screenings until age 50, the number of women in their 40s undergoing mammograms slightly declined, a new study shows.The study, carried out by the Mayo Clinic, found a drop of roughly 6 percent in the number of

The warning, stemming from an April inspection by U.S. regulators, does not restrict production or product shipments from the plant in La Aurora de Heredia, Costa Rica, Hospira said on Tuesday in a regulatory filing with the U.S. Securities and Exchange Commission.Among the issues cited by the FDA w

The Food and Drug Administration has agreed to give priority status to its review of three new uses for the anticlotting drug Xarelto, Johnson & Johnson announced Monday.The company is asking the agency to approve the drug to treat deep vein thrombosis and pulmonary embolism, and to prevent recu

New drugs for breast cancer and multiple myeloma won approval from the Food and Drug Administration on Friday, expanding options for patients in advanced stages of those diseases.The breast cancer drug, Afinitor from Novartis, seems to expand the time that endocrine therapy can keep the disease in c